English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Mesenchymal stem cells derived from adipose tissue (AT-MSCs) offer unique advantages for the application of gene-based therapies: they are abundant, easily harvested, replenishable and home to damaged tissues undergoing regeneration. “These unique features of AT-MSCs led us to explore the feasibility of using them for gene delivery to the liver,” explains Sihong Song, corresponding author of this report, which appeared in the Journal of Hepatology.

Mesenchymal stem cells from adipose tissue could be used to deliver gene therapy to the liver